AUSTRALIA'S #1 ONLINE CPD EDUCATION PLATFORM

Live webinar - Conducting a review of T2D patients in primary practice: A whole-of-practice approach
In this webinar, A/Prof Ralph Audehm and another HCP colleague will take you through how their GP practices conduct a best-practice recall and review of their patients with T2D, using a whole-of-practice...
Podcast series: Vaccine preventable diseases in older adults
Listen to practicing general practitioner, Anita Sharma, discuss the importance of vaccination in adult populations and the impact primary care can have in protecting older Australians from infectious diseases...
ALM: IN Control advanced course: INs and outs of INsulin INitiation and Intensification
This GP-led, on-demand advanced course, supported by diabetes specialists, will provide practical guidance on the role and implementation of insulin in the contemporary management of diabetes in the primary...
Continuous glucose monitoring and flash glucose monitoring in type 2 diabetes
This module explores the role of CGM and Flash GM in providing effective diabetes care, and provides guidance on interpreting glucose profiles and setting personalised targets.
ALM: Asthma in Australia: Practical solutions for challenges in primary care
This activity covers best practice diagnostic and management principles for asthma, strategies for preventative care and reducing the risk of hospitalisation.
Busting the myths and redefining myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
ME/CFS is a complex, chronic, debilitating disease with systemic effects, which is estimated to affect up to 250,000 Australians. This module aims to educate GPs and others working in the primary care space...

Managing epilepsy in older people: Optimising outcomes in general practice

Hours: 2 | RACGP: 4pts | ACRRM: 2hrs

Epilepsy is a common problem for older adults, and has a greater impact in older people compared to younger populations. This module describes key differences between the causes and presentation of epilepsy in older versus younger people, as well as special considerations for prescribing antiseizure drugs for older people. This two-hour activity contains a online learning module as well as a patient review exercise involving preparation of a GP Management Plan for a patient.

T2D injectables: 1. Intensifying to first injectable therapy in uncomplicated type 2 diabetes

Hours: 2 | RACGP: 4pts | ACRRM: 2hrs

This education module focuses on a case study of an uncomplicated patient with type 2 diabetes, and the process of intensifying to first injectable therapy. Expert video commentary throughout the module helps step the participant through the decision cycle from the ADA/EASD consensus guidelines for T2D. This module also includes Australian recommendations for patients fasting during Ramadan.

T2D injectables: 2. Intensifying to first injectable therapy in patients with ASCVD risk

Hours: 1.5 | RACGP: 3pts | ACRRM: 2hrs

In this education module, the participant will work through a case study of a type 2 diabetes patient with ASCVD risk factors. The case study uses the decision cycle from the ADA/EASD consensus guidelines for T2D, and features expert video commentary. The module also discusses patient-related concerns leading to clinical inertia, including useful management decisions when faced with this issue.

T2D injectables: 3. Intensifying to first injectable therapy in patients with established ASCVD

Hours: 1.5 | RACGP: 3pts | ACRRM: 2hrs

This education module takes a case-study based look at the management of a type 2 diabetes patient with established ASCVD. Featuring expert video commentary, participants will use the decision cycle from the ADA/EASD consensus guidelines for T2D to work through a hypothetical case study. This module also discusses GP-related causes of clinical inertia, as well as additional patient factors such as obesity, low health literacy and diabetes distress.

Rethinking first injectable therapies in type 2 diabetes: A practical approach

Advanced course | Hours: 5 | RACGP: 40pts | ACRRM: 5hrs

This advanced course explores how to initiate injectable therapy in a patient with type 2 diabetes who remains above their glycaemic target despite taking dual or triple oral therapy. The activity works through 3 in-depth case-studies: a patient with uncomplicated T2D, a patient with ASCVD risk, and a patient with established ASCVD.

Pages

RELX Group plc